Sinopharm Group Co. Ltd. (SHTDY)

USD 13.79

(0.0%)

Annual Cash Flows

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Operating Cash Flow 17.17 Billion 20.96 Billion 9.3 Billion 11.15 Billion 18.77 Billion 3.65 Billion
Net Income 19.51 Billion 18.56 Billion 17 Billion 15.59 Billion 13.75 Billion 12.2 Billion
Depreciation & Amortization 4.43 Billion 4.16 Billion 3.92 Billion 3.59 Billion 3.11 Billion 1.39 Billion
Deferred income taxes - - - -2.54 Billion -1.86 Billion -3.3 Billion
Stock-based compensation - - - -18.56 Million 5.75 Million 19.98 Million
Change in working capital -3.86 Billion -2.07 Billion -12.1 Billion -8.71 Billion 463.99 Million -10.66 Billion
Other non-cash items -98.92 Million 308.65 Million 484.19 Million 3.24 Billion 3.29 Billion 4 Billion
Investing Cash Flow -944.53 Million -3.58 Billion -1.26 Billion -2.2 Billion -6.79 Billion -5.9 Billion
Investments in PPE -2.33 Billion -2.41 Billion -2.25 Billion -2.08 Billion -2.54 Billion -3.4 Billion
Acquisitions -31.85 Million -336.7 Million -488.35 Million -2.42 Billion -1.23 Billion -295.12 Million
Investment purchases -29.06 Million -100 Million -75 Million -40.02 Million -115.15 Million -537.04 Million
Sales/Maturities of investments 53.05 Million 211.53 Million 298.62 Million 23.65 Million 55.24 Million 60.11 Million
Other Investing Activities 102.91 Million -946.91 Million 1.25 Billion 2.32 Billion -2.95 Billion -1.73 Billion
Financing Cash Flow -7.64 Billion -5.69 Billion -14.69 Billion 2.02 Billion -13.08 Billion 10.31 Billion
Debt repayment -2.5 Billion -101.7 Billion -104.7 Billion -96.83 Billion -91.29 Billion -66.76 Billion
Dividends payments -2.55 Billion -2.34 Billion -2.15 Billion -1.86 Billion -1.75 Billion -1.57 Billion
Common Stock Repurchased - - - 96.84 Billion 78.85 Billion 75.95 Billion
Common Stock Issuance - - - 3.6 Billion 50.15 Million 2.83 Million
Other Financing Activities 2.72 Million 98.35 Billion 92.16 Billion 287.39 Million 1.06 Billion 2.7 Billion
Accounts receivables -14.84 Billion 710.12 Million -26.71 Billion -22.63 Billion -12.96 Billion -24.39 Billion
Accounts payables - -710.12 Million 26.71 Billion 22.63 Billion 12.96 Billion -
Inventory 455.55 Million -9.5 Billion -4.34 Billion -3.67 Billion -6.12 Billion -4.92 Billion
Other working capital 3.7 Billion 7.43 Billion -7.75 Billion -5.04 Billion 6.58 Billion -5.73 Billion
Cash at beginning of period 55.22 Billion 43.52 Billion 50.17 Billion 39.19 Billion 40.29 Billion 32.24 Billion
Cash at end of period 63.8 Billion 55.22 Billion 43.52 Billion 50.17 Billion 39.19 Billion 40.29 Billion
Capital Expenditure -2.33 Billion -2.41 Billion -2.25 Billion -2.08 Billion -2.54 Billion -3.4 Billion
Effect of forex changes on cash 2.38 Million 11.51 Million 3.04 Million 8.59 Million -3.58 Million -6.44 Million
Net cash flow / Change in cash 8.58 Billion 11.69 Billion -6.64 Billion 10.98 Billion -1.1 Billion 8.05 Billion
Free Cash Flow 14.83 Billion 18.54 Billion 7.05 Billion 9.06 Billion 16.22 Billion 249.61 Million

Cash Flow Charts